Perioperative medicine & outcomes

Peripheral nerve‐blocks and associations with length of stay and readmissions in fast‐track total hip and knee arthroplasty

Acta Anaesthesiol ScandPublished Observational cohort study

Authors' conclusion

Routine use of peripheral nerve blocks was not associated with early discharge or 30-days readmissions in fast-track THA and TKA.

Study context

Population
Fast-track THA and TKA patients in six Danish Arthroplasty Centers, January to August 20172,027 THA, 1432 TKA
Exposure
Peripheral nerve blocks (PNB) vs no PNB within fast-track protocols
Outcome
LOS >1 day, LOS >4 days and 30-days readmissions
Methodological detailsmulticentre, prospective recording, multiple logistic regression
  • Multicentre
  • Prospective recording
  • Multiple logistic regression

Main finding

As reported in the abstract

LOS >1 day, LOS >4 days, 30-days readmissions (TKA)
PNB vs No PNBOdds ratio (CI)P value
LOS >1 day, TKA
1.19(0.82–1.72)
P = 0.354
LOS >4 days, TKA
1.4(0.68–2.89)
P = 0.359
30-days readmissions, TKA
1.02(0.63–1.65)
P = 0.935

Observational data: associations, not effects.

Further findings

Overall length of stay (LOS)

Median LOS (IQR 1-2), days
1

30-days readmission rate, all patients

Readmission rate
5.3% (CI:4.6-6.1)

PNB use

TKA
40.7% (CI:38.2-43.3)
THA
2.7% (CI:2.0-3.5)
Interdepartmental variation, TKA
0.0-89.0%

Safety

OutcomePNBNo PNB
Mobilization, pain or opioid-related complications (TKA)2.1% (CI 1.2–3.6)0.1% (CI 0.02–0.7)
Falls (TKA)0.9% (CI 0.4–2.0)0.5% (CI 0.2–1.2)
Mobilization, pain or opioid-related complications (THA)3.7% (CI 1.0–12.6)0.6% (CI 0.3–1.0)
Falls (THA)0.0% (CI 0.0–6.6)0.8% (CI 0.5–1.3)

Original publication

Peripheral nerve‐blocks and associations with length of stay and readmissions in fast‐track total hip and knee arthroplasty. Acta Anaesthesiol Scand. Published 28 November 2022. doi:10.1111/aas.14169

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.